Cadrenal Therapeutics, Inc. (CVKD) › Cash & EquivalentsCadrenal Therapeutics, Inc. (CVKD) — Cash & EquivalentsAnnual figures by period end, from SEC filings.2022-12-31: $32.6K2023-12-31: $8.40M2024-12-31: $10.02M2025-12-31: $4.01M$4.01M2022-12-31Cash & Equivalents (USD)2025-12-31Period endedCash & EquivalentsChange YoYSource filing2025-12-31$4.01M-60.0%2026-03-31Balance as of period end2024-12-31$10.02M+19.2%2026-03-31Balance as of period end2023-12-31$8.40M+25685.6%2024-03-11Balance as of period end2022-12-31$32.6K—2024-03-11Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)